DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/f287d264/clinical_chemistry) has announced the addition of GlobalData's new report "Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" to their offering.
GlobalData's new report, Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 provides key market data on the Clinical Chemistry market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within six market categories -Clinical Chemistry Rapid Tests & POC, Urine Analysis, Clinical Chemisty Analyzers, Metabolite Chemistry Reagents, Enzyme Chemistry Reagents and Electrolyte Chemistry Reagents. The report also provides company shares and distribution shares data for the overall Clinical Chemistry market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope:
- Market size data for Clinical Chemistry market categories - Clinical Chemistry Rapid Tests & POC, Urine Analysis, Clinical Chemisty Analyzers, Metabolite Chemistry Reagents, Enzyme Chemistry Reagents and Electrolyte Chemistry Reagents.
- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the six market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
- 2010 company shares and distribution shares data for the overall Clinical Chemistry market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Clinical Chemistry market in BRICS.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., Abbott Laboratories, Shanghai Kehua Bio-engineering Co., Ltd., Mindray Medical International Limited, Transasia Bio-Medicals Ltd. and Sysmex Corporation.
Reasons to Buy:
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Clinical Chemistry competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Companies Mentioned
- F. Hoffmann-La Roche Ltd.
- Siemens Healthcare
- Ortho-Clinical Diagnostics Inc.
- Beckman Coulter, Inc.
- Abbott Laboratories
- Shanghai Kehua Bio-engineering Co., Ltd.
- Mindray Medical International Limited
- Transasia Bio-Medicals Ltd.
- Sysmex Corporation
- Trivitron Healthcare Pvt Ltd.
- Span Diagnostics Ltd.
- Olympus Corporation
For more information visit http://www.researchandmarkets.com/research/f287d264/clinical_chemistry
Source: GlobalData